JPM Thematics - Genetic Therapies C2 Fonds
85,78
CHF
+0,69
CHF
+0,81
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Wuxi AppTec Co Ltd | CNE100003F19 | 3,44% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,29% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,27% |
| Novartis AG Registered Shares | CH0012005267 | 3,26% |
| Avidity Biosciences Inc Ordinary Shares | US05370A1088 | 3,12% |
| Astellas Pharma Inc | JP3942400007 | 3,01% |
| Gilead Sciences Inc | US3755581036 | 3,00% |
| CRISPR Therapeutics AG | CH0334081137 | 2,97% |
| PTC Therapeutics Inc | US69366J2006 | 2,93% |
| Amgen Inc | US0311621009 | 2,81% |
| Sonstige | 68,92% |